Can Direct-to-Consumer Genetic Testing Predict Rheumatological Diseases?

Genetic testing, such as 23andMe, has been approved by the FDA for direct-to-consumer genetic testing.  However, this type of testing has not been approved to predict rheumatic diseases. Research is being conducted to determine if this type of direct-to-consumer genetic testing will eventually be beneficial in the field of rheumatology for disease diagnosis and prediction.

Read the source article at


What are your thoughts on direct-to-consumer genetic testing? Share your stories, thoughts, and hopes with the Patient Worthy community!

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email